Clinical Trials Logo

Recurrent Chronic Lymphoid Leukemia clinical trials

View clinical trials related to Recurrent Chronic Lymphoid Leukemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT02787369 Active, not recruiting - Clinical trials for Recurrent Chronic Lymphoid Leukemia

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

Start date: May 2016
Phase: Phase 1
Study type: Interventional

This research study is studying a drug called ACY-1215 in combination with ibrutinib or idelalisib as a possible treatment for Relapsed or Refractory Chronic Lymphocyic Leukemia (CLL).